RAC 0.60% $1.69 race oncology ltd

Ann: Expanded Heart Protection Discovery for Zantrene, page-152

  1. 226 Posts.
    lightbulb Created with Sketch. 113
    Developing drugs is a very long and very expensive process from discovery through various trials until getting FDA approval. I could take several years and billions of dollars and at any time - including after approval - there is the chance not to succeed due to various reasons, like some adverse effect, further trial requirements, competitive and better drug hits the market, etc. Would you invest a large amount of money unless you would expect a sizeable return in a high risk - often binary outcome - product?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.